US2023111075A1PendingUtilityA1
Methods and systems for using encapsulated microbubbles to process biological samples
Assignee: UNIV NORTH CAROLINA CHAPEL HILLPriority: Oct 4, 2012Filed: Oct 6, 2022Published: Apr 13, 2023
Est. expiryOct 4, 2032(~6.2 yrs left)· nominal 20-yr term from priority
Inventors:William Perry JanzenSamantha Gail PattendenChatura Nadisha JayakodyJason Eric StreeterPaul DaytonCameron Champion WoodSiddharth Kaup Shenoy
C12N 15/1003G01N 1/38G01N 2001/387C12Q 1/6806C12N 15/10C12M 23/36
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and systems for using encapsulated microbubbles to process biological samples are disclosed. According to one aspect, a method for using encapsulated microbubbles to process a biological sample includes creating a mixture comprising encapsulated microbubbles mixed with a biological sample and adding activation energy to the mixture to cause at least some of the microbubbles to oscillate or burst and thereby process the sample, including effecting cell lysis, shearing DNA, and/or performing tissue dispersion.
Claims
exact text as granted — not AI-modified1 . A system for delivering microbubbles to a biological sample, the system comprising:
a container for holding a solution of microbubbles or a solution that will formulate encapsulated microbubbles when processed; and at least one outlet for delivering the solution of microbubbles to a biological sample.
2 . The system of claim 1 comprising an energy source for providing activation energy to the microbubbles that causes the microbubbles to oscillate or burst and thereby process the sample.
3 . The system of claim 2 wherein the activation energy comprises thermal, sonic, or light energy, optionally wherein the activation energy is ultrasound having a frequency in the range from 0.01 MHz to 10 MHz.
4 . (canceled)
5 . The system of claim 2 wherein the biological sample comprises DNA or DNA that has been cross-linked to protein and wherein processing the sample comprises shearing the DNA.
6 . The system of claim 2 wherein the biological sample comprises cells and wherein processing the sample comprises effecting cell lysis, optionally wherein the cells comprise bacteria or yeast cells.
7 . (canceled)
8 . The system of 2 wherein the sample comprises tissue and wherein processing the sample comprises performing tissue dispersion.
9 . The system of claim 1 wherein the sample comprises at least one of fresh tissue, cryogenically preserved tissue, and fixed and paraffin embedded tissue.
10 . The system of claim 1 wherein the container includes a plurality of outlets for delivering the solution of microbubbles or the solution that will formulate encapsulated microbubbles when processed to different wells of a multi-well plate.
11 . The system of claim 1 wherein a majority of the microbubbles have a diameter in the range from 0.1 microns to 10 microns.
12 . The system of claim 1 comprising a second container for holding dehydrated microbubbles, which are mixed with a solution and thus re-suspended, and that provides the solution of microbubbles to the container for holding the solution of microbubbles.
13 . (canceled)
14 . The system of claim 1 comprising a microbubble forming apparatus for processing the solution to form encapsulated microbubbles within the solution that will formulate encapsulated microbubbles when processed.
15 - 24 . (canceled)
25 . The system of claim 1 where the solution that will formulate encapsulated microbubbles when processed includes surfactants, emulsifiers, polymers, or proteins.
26 . The system of claim 14 wherein the microbubble forming apparatus comprises a probe for adding sonic energy to the solution that will formulate encapsulated microbubbles when processed in the presence of gas to induce the formation of the microbubbles in the solution before it is added to the biological sample.
27 . The system of claim 14 wherein the microbubble forming apparatus comprises a mechanical mixer or impeller that rapidly agitates the solution that will formulate encapsulated microbubbles when processed in the presence of gas, forming the microbubbles in the solution, before the solution is added to the biological sample.
28 . The system of claim 14 wherein the microbubble forming apparatus comprises at least one fluid system that forces gas surrounded by liquid through an opening to result in microbubble production.
29 . The system of claim 14 wherein the microbubble forming apparatus comprises at least one fluid system that forces gas through a porous membrane to form the microbubbles.
30 . The system of claim 1 wherein the solution that will formulate encapsulated microbubbles when processed comprises encapsulated liquid droplets, optionally wherein a majority of the droplets have a diameter in the range from 100 nanometers to 750 nanometers.
31 . The system of claim 30 wherein the droplets comprise a shell surrounding a liquid core that converts to a gas upon the addition of acoustic, thermal, or optical energy.
32 . The system of claim 31 wherein the liquid core comprises a hydrocarbon or perfluorocarbon, optionally at least one of isopentane, perfluoropentane, perfluorohexane, perfluorobutane, and perfluoropropane.
33 - 34 . (canceled)
35 . The system of claim 30 comprising an energy source for converting the droplets into microbubbles, optionally wherein the energy source is configured to convert the droplets into microbubbles before or after the solution is delivered to the biological sample.
36 . (canceled)Join the waitlist — get patent alerts
Track US2023111075A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.